Chitosan and Its Derivatives as Nanocarriers for Drug Delivery
Molecules · 13.03.2025 · 30 (6) · 1297
DOI: 10.3390/molecules30061297 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 13.03.2025. Verfasst von Ranu Biswas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, WB, India. Hauptthemen laut MEDLINE: Chitosan, Drug Carriers, Nanoparticles, Drug Delivery Systems. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chitosan (CS) occurs naturally as an alkaline polysaccharide and has been demonstrated to have several activities of a biological nature. Additionally, as CS chains have functional hydroxyl and amino groups that are active, their applications can be expanded by chemically or molecularly altering the molecules to incorporate new functional groups. Due to its outstanding qualities, including biodegradability, biocompatibility, non-toxicity, and accessibility, it has received significant interest in all areas of biomedicine and nanomaterials being extremely promising as drug nanocarrier. The last decades have produced a lot of interest in CS-based nanoparticles (CSNPs), with an increasing number of research papers from around 1500 in 2015 to almost 5000 in 2024. The degree of crosslinking, the particulate system’s shape, size, and density, in addition to the drug’s physical and chemical properties, all have a role in how the drug is transported and released from CSNPs. When creating potential drug delivery systems based on CSNPs, all these factors must be considered. In earlier, CSNPs were employed to enhance the pharmacotherapeutics, pharmacokinetics, and solubility properties of drugs. By investigating its positively charged characteristics and changeable functional groups, CS has evolved into a versatile drug delivery system. The drug release from CSNPs will definitely be influenced by various changes to the functional groups, charges, and polymer backbone. This review mainly discusses the most important results published in the last decade. Despite the promising advantages of CSNPs, challenges related to the translation into clinical stages remain and further in vitro and in vivo studies are mandatory.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, WB, India.
- Faculty of Medicine, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- "Cristofor Simionescu" Faculty of Chemical Engineering and Environmental Protection, "Gheorghe Asachi" Technical University of Iasi, 700050 Iasi, Romania.
- Faculty of Medicine, "Apollonia" University of Iasi, 700511 Iasi, Romania.
- Academy of Romanian Scientists, 050045 Bucharest, Romania.
ORCID-Profile: Ranu Biswas, Md Ahesan Ansari, Iustina Petra Condiuc, Leonard Ionut Atanase
Zitieren
APA
Biswas, R., Mondal, S., Ansari, M. A., Sarkar, T., Condiuc, I. P., Trifas, G., & Atanase, L. I. (2025). Chitosan and Its Derivatives as Nanocarriers for Drug Delivery. Molecules, 30(6), 1297. https://doi.org/10.3390/molecules30061297
Vancouver
Biswas R, Mondal S, Ansari MA, Sarkar T, Condiuc IP, Trifas G, et al. Chitosan and Its Derivatives as Nanocarriers for Drug Delivery. Molecules. 2025;30(6):1297. doi:10.3390/molecules30061297
BibTeX
@article{Biswas2025,
author = {Biswas, Ranu and Mondal, Sourav and Ansari, Md Ahesan and Sarkar, Tanima and Condiuc, Iustina Petra and Trifas, Gisela and Atanase, Leonard Ionut},
title = {Chitosan and Its Derivatives as Nanocarriers for Drug Delivery},
journal = {Molecules},
year = {2025},
volume = {30},
number = {6},
pages = {1297},
doi = {10.3390/molecules30061297}
}
EUVIMED